Lisa Wray

Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial

Stephan Kadauke, Regina M. Myers, Yimei Li et al. · Journal of Clinical Oncology · 2021 · 201 citations · Full text

Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

Regina M. Myers, Yimei Li, Allison Barz Leahy et al. · Journal of Clinical Oncology · 2021 · 177 citations · Full text

Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.

Angela DeMichele, Anne-Marie Martin, Rosemarie Mick et al. · PubMed · 2003 · 155 citations

Breast Oncology, High-risk Breast Cancer, Genetic Epidemiology +24

CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials

Allison Barz Leahy, Haley Newman, Yimei Li et al. · The Lancet Haematology · 2021 · 114 citations · Full text

Cell Therapy, Medicine, Immunology +8

Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy

Allison Barz Leahy, Kaitlin J. Devine, Yimei Li et al. · Blood · 2021 · 108 citations · Full text